The IM-ER4 (3 month retention) indicator reports the number and percentage of adults and children newly enrolled on antiretroviral therapy (ART) 4 months prior to the reporting period end date in a one-month enrollment cohort period who have either ART pick-up between 61 and 120 days after ART initiation date.